Question 1

Who are the top researchers at Pharmatest (Finland)?

Accepted Answer

Ranked on the quality score, Esa J. Alhoniemi, Jussi M. Halleen and Jenni H. Mäki-Jouppila lead among researchers whose main affiliation is Pharmatest (Finland).

Question 2

What are the most cited papers from Pharmatest (Finland)?

Accepted Answer

The most cited paper from Pharmatest (Finland) is "Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib" (Heikki Joensuu, Eva Wardelmann, Harri J. Sihto et al., 2017), with 192 citations. Next come "Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models" (178) and "Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover" (167).

Question 3

Which research topics does Pharmatest (Finland) publish most on?

Accepted Answer

By volume in 2022-now: Prostate Cancer Treatment and Research, Osteoarthritis Treatment and Mechanisms, Radiopharmaceutical Chemistry and Applications and Inflammatory mediators and NSAID effects.

Question 4

Which keywords describe research at Pharmatest (Finland)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Cancer Treatment, Prostate Cancer, Immunotherapy, Inflammation, Breast Cancer, Targeted Therapy, PET Imaging and Genetic Mutations.

Question 5

Which fields of science does Pharmatest (Finland) work in?

Accepted Answer

In all years, 71% of research at Pharmatest (Finland) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (20%), Engineering (4%). It does 2.8× the world's share of Health Sciences.

Question 6

Is Pharmatest (Finland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 61% lower than in 2018-2021.